X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-12-02 | LGVN | Baluch Khoso | Dir | S - Sale | $2.07 | -1,250 | 23,750 | -5% | -$2,588 | ||||||
| DM | 2024-04-10 | LGVN | Hare Joshua | Chief Scientific Officer, 10% | P - Purchase | $2.35 | +148,936 | 633,280 | +31% | +$350,000 | |||||
| D | 2024-04-11 | LGVN | Hashad Mohamed Wa'El Ahmed | CEO | P - Purchase | $2.35 | +10,638 | 19,616 | +118% | +$24,999 | |||||
| DM | 2024-04-10 | LGVN | Soffer Rock | Dir | P - Purchase | $2.35 | +138,298 | 208,534 | +197% | +$325,000 | |||||
2024-01-10 | LGVN | Ross Cathy | Dir | P - Purchase | $1.31 | +5,000 | 10,000 | +100% | +$6,545 | ||||||
| M | 2023-12-28 | LGVN | Baluch Khoso | Dir | P - Purchase | $1.43 | +10,000 | 15,000 | +200% | +$14,257 | |||||
2023-12-28 | LGVN | Pfeffer Jeffrey | Dir | P - Purchase | $1.35 | +10,000 | 15,000 | +200% | +$13,500 | ||||||
| M | 2023-06-27 | LGVN | Clavijo James | CFO, Treasurer | S - Sale | $3.47 | -23,532 | 47,303 | -33% | -$81,541 | |||||
2023-01-27 | LGVN | Hare Joshua | Chief Scientific Officer, 10% | S - Sale | $4.28 | -20,000 | 7,846,777 | 0% | -$85,600 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |